IndiaMTF — home
Stock

Jubilant Pharmova — MTF Book

JUBLPHARMA · Jubilant Pharmova Limited
Health Technology

Daily Margin Trading Facility book for Jubilant Pharmova across NSE and BSE, from 02 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Jubilant Pharmova’s MTF book?

Jubilant Pharmova Limited (JUBLPHARMA) has ₹37 crore funded under Margin Trading Facility across NSE and BSE as of 26 Oct 2026 — 0.02% of India’s MTF book, ranking #776. Over 1M (the last 30 trading days) the funded value has risen 16.6%, with the number of shares under margin up 17.6%.

Funded value
₹37 Cr
as of 26 Oct 2026
Rank in book
#776
1,774 days tracked
Share of book
0.02%
of the whole NSE + BSE book
Peak funded
₹451 Cr
on 03 Aug 2017
Largest single-day addition
+₹450 Cr
on 03 Aug 2017
Largest single-day unwind
−₹450 Cr
on 04 Aug 2017
Free-float market cap
₹7,726 Cr
full market cap ₹14,925 Cr · 51.8% free float · Small cap
MTF share of free float
0.43%
0.2× the median small cap · 0.5× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.22%0.43%0.64%0.84%Feb 2024Oct 2026
View as table: share of free float on margin30 months
Month-end% of free float
26 Oct 20260.429%
30 Sep 20260.386%
31 Aug 20260.449%
31 Jul 20260.401%
30 Jun 20260.362%
29 May 20260.349%
30 Apr 20260.424%
30 Mar 20260.431%
27 Feb 20260.501%
30 Jan 20260.478%
31 Dec 20250.590%
28 Nov 20250.651%
31 Oct 20250.617%
30 Sep 20250.600%
29 Aug 20250.510%
31 Jul 20250.479%
30 Jun 20250.445%
30 May 20250.374%
30 Apr 20250.295%
28 Mar 20250.304%
28 Feb 20250.346%
31 Jan 20250.428%
24 Sep 2024†0.505%
29 Aug 2024†0.561%
31 Jul 20240.562%
26 Jun 2024†0.504%
31 May 20240.772%
30 Apr 20240.768%
28 Mar 20240.564%
29 Feb 20240.614%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How JUBLPHARMA’s funded book divides across the two exchanges, as of 26 Oct 2026.
NSE
NSE ₹36 Cr · 97.3%BSE ₹1 Cr · 2.7%

MTF vs Price

Margin-funded outstanding for JUBLPHARMA in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹938.30
as of 23 Oct 2026
Price, 1M
−7.9%
adjusted for splits and bonuses
Delivery, 20-day avg
52.3%
of traded volume actually settled
Sessions to unwind
2
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹2−6.2%−6.8%
−25,791
+0.0%unwinding as it falls
10D+₹3+10.2%+11.8%
+37,293
+0.7%building into strength
1M+₹5+16.6%+17.6%
+52,929
−7.9%building as it falls
3M+₹3+9.6%+12.9%
+40,415
−2.8%building as it falls
6M−₹2−4.9%−0.2%
−700
−0.8%unwinding as it falls
1Y−₹17−31.3%−26.0%
−1,24,105
−16.1%unwinding as it falls

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where JUBLPHARMA has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

JUBLPHARMA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
26 Oct 202637−₹20.02%776
23 Oct 202639−₹00.03%754
22 Oct 202639−₹20.03%761
21 Oct 202641−₹00.03%747
19 Oct 202641−₹10.03%748
16 Oct 202642+₹00.03%740
15 Oct 202642−₹20.03%747
14 Oct 202644+₹20.03%727
13 Oct 202641−₹20.03%750
12 Oct 202643+₹100.03%732
09 Oct 202633−₹00.02%836
08 Oct 202633+₹00.02%833
07 Oct 202633+₹10.02%835
06 Oct 202633−₹00.02%832
05 Oct 202633+₹00.02%830
01 Oct 202633−₹10.02%832
30 Sep 202634+₹10.02%828
29 Sep 202633−₹00.02%833
28 Sep 202633+₹00.02%835
25 Sep 202633+₹00.02%836
24 Sep 202633+₹00.02%844
23 Sep 202632+₹10.02%847
22 Sep 202631+₹00.02%864
21 Sep 202630+₹20.02%868
18 Sep 202629−₹30.02%884
17 Sep 202632+₹10.02%843
16 Sep 202631−₹00.02%852
15 Sep 202631+₹10.02%847
11 Sep 202630−₹10.02%876
10 Sep 202631—0.02%869

JUBLPHARMA within Health Technology

Ranked #45 of 61 funded Health Technology stocks, carrying 0.6% of that sector’s margin book. Its 0.43% of free float on margin is 0.5× the sector median of 0.89%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
43ABBOTINDIAAbbott India₹380.6%—−41.2%
44TORNTPHARMTorrent Pharmaceuticals₹370.6%0.05%−3.4%
45JUBLPHARMAJubilant Pharmova₹370.6%0.43%+16.6%
46BAJAJHCAREBajaj Healthcare₹350.5%6.71%−5.1%
47SANOFISanofi India₹340.5%1.02%−9.7%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.